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Pleiotropic effects of hepatocyte growth factor in proximal tubule
involve different signaling pathways. Hepatocyte growth factor
(HGF) accelerates renal tubule cell regeneration and induces
tubulogenic differentiation via the intracellular tyrosine kinase
(TK) domain of its receptor, the proto-oncogene c-Met. We tested
whether different signaling pathways may be involved by examin-
ing HGF binding and effects on cell proliferation, migration,
scattering, and tubulogenic differentiation in the bipolar differen-
tiating rabbit proximal tubule cell line PT-1 under serum-free
conditions in the presence or absence of the protein TK inhibitors
(PTKIs) herbimycin-A, genistein, methyl-2,5-dihydroxycin-
namate, and geldanamycin. These PTKIs inhibit pp60c-src, a
nonreceptor TK involved in cell-growth control. HGF bound to a
single high-affinity receptor class, increased microvilli numbers
1.5-fold, enhanced cell proliferation and migration 1.8-fold, and
stimulated formation of tubule structures 2.2-fold. PTKI inhibited
the mitogenic and motogenic effects of HGF with different
potencies and comparable maximal effects but had no specific
influence on HGF-induced tubulogenic cell differentiation. These
data underline the importance of pp60c-src in mediating mitogenic
and motogenic effects of HGF, whereas stimulation of tubulo-
genic cell differentiation may be transduced by a pp60c-src–
independent pathway.
Acute renal failure is relatively common and potentially
life threatening. Because growth factors (GFs) are impor-
tant in regeneration of damaged renal epithelia, they might
be effective for treating renal failure and accelerating renal
repair [1]. Hepatocyte GF (HGF) is one important reno-
tropic GF and stimulates renal tubule cell proliferation in
the remnant kidney after unilateral nephrectomy [2] and
promotes renal tubule cell regeneration in experimental
acute renal failure [3]. As a multifunctional cytokine, HGF
acts on various cells, including renal proximal tubule cells,
via high-affinity binding to the receptor tyrosine kinase
(TK) c-Met [4]. c-Met autophosphorylates on stimulation
by HGF and then binds via a multifunctional docking site to
various intracellular proteins containing src-homology-2
domains, such as pp60c-src and PI3 kinase [4, 5]. Which
pathway mediates which response is, however, generally
unknown. We thus investigated binding, signal transduc-
tion, and action of HGF in the bipolar differentiating rabbit
proximal tubule cell line PT-1 [6].
METHODS
Human recombinant HGF was obtained from R&D
Systems (Wiesbaden, Germany). Protein TK inhibitors
(PTKI) geldanamycin, genistein, herbimycin A, and the
stable erbstatin analog methyl-2,5-dihydroxycinnamate
(MDC) were obtained from GIBCO BRL (Eggenstein,
Germany) and dissolved in dimethylsulfoxide. PT-1 cells
were grown in Dulbecco’s minimal essential medium as
previously described [6]. To characterize the actions of
HGF without influence of serum GFs, cells were grown
under defined serum-free conditions and thus showed
minimal further proliferation and were viable for five to
seven days (trypan blue exclusion). HGF binding was
assayed in confluent cell monolayers incubated with 125I-
HGF (20,000 cpm) and various concentrations of unlabeled
HGF (10 pM-0.1 mM) and number and affinity of HGF
receptors were determined [6]. Short-term effects of HGF
on cell proliferation were assessed using a nonradioactive
cell proliferation assay (CellTiter 96TM, technical bulletin,
#TB112; Promega, Madison, WI, USA) with results com-
parable to the [3H]thymidine incorporation assay. After
48-hours incubation with HGF and PTKI, cell numbers
were determined (Coulter Counter, Krefeld, Germany).
For all further experiments, PTKI were used in concentra-
tions yielding 50% inhibition of cell growth (EC50). The
effect of HGF and PTKI on cell scattering was scored
semiquantitatively [7]. Cell migration was studied by micro-
carrier bead motility assays using cytodex 2 collagen-coated
microcarrier beads [8]. Tubule structures were quantified
by light microscopy; microvilli formation on the apical cell
membrane was assessed using scanning electron micros-
copy. If not otherwise indicated, data are presented as the
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mean 6 SEM of 4 to 10 independent experiments. The
one-tailed Student’s t-test for unpaired data was used to
test means. P , 0.05 was considered significant.
RESULTS AND DISCUSSION
Hepatocyte growth factor bound to a single class of
high-affinity sites (68,500 6 3,000 per cell, Kd 2.5 6 0.2 nM)
in confluent PT-1 cells.
Hepatocyte growth factor stimulated cell growth al-
ready at 10 pM and maximally at 1 nM (used for all further
experiments). The proliferative response could first be
demonstrated after one hour, and cell number increased
1.8-fold after 48 hours (P , 0.01 vs. serum-free controls;
Fig. 1A). All PTKI inhibited HGF-induced cell growth
dose dependently (Table 1). Geldanamycin had the
highest potency (EC50 0.01 mM). Herbimycin A,
genistein, and MDC had comparable effects at 10-, 100-
and 1,000-fold higher concentrations, respectively. HGF
enhanced migration of PT-1 cells from 112 6 11 to 205 6
15 cells/mm2 (P , 0.01; Fig. 1B). All PTKI inhibited
HGF-induced migration (Table 1). Cells cultured in
collagen type I gels or under conventional conditions
showed scattered phenotypes when incubated with HGF
(Fig. 2). All PTKI inhibited the stimulatory effects of
HGF on cell scattering with potencies as for cell prolif-
eration and migration.
Fig. 1. Effects of hepatocyte growth factor (HGF) on PT-1 cell proliferation and differentiation and modulation by different protein tyrosine kinase
inhibitors (PTKI). PT-1 cells were grown for 48 hours under serum-free conditions in the presence of 1 nM HGF alone or in combination with different
PTKI at concentrations yielding half-maximal inhibition of cell growth (geldanamycin 0.01 mM, genistein 1 mM, herbimycin A 0.1 mM, and
methyl-2,5-dihydroxycinnamate (MDC) 10 mM). (A) Cell proliferation. (B) Cell migration. (C) Formation of tubule structures. (D) Formation of
microvilli. Data are means 6 SEM of six independent experiments. *P , 0.05, **P , 0.01 versus serum-free control. Symbols are: (M) control; (f) HGF;
( ) HGF 1 genistein; ( ) HGF 1 MDC; ( ) HGF 1 geldanamycin; (s) HGF 1 herbimycin A.
Table 1. Effects of different protein tyrosine kinase inhibitors on
hepatocyte growth factor-induced proliferation, migration, and











Geldanamycin 0.001 85 6 15% 91 6 5%
0.01 62 6 17%a 56 6 6%a
0.1 26 6 8%b 26 6 11%b
Herbimycin 0.01 93 6 18% 71 6 30%
0.1 60 6 21%a 58 6 18%a
1 30 6 11% 46 6 27%a
Genistein 0.1 99 6 20% 92 6 6%
1 69 6 12%a 58 6 4%a
10 52 6 16%b 31 6 14%b
Methyl-2.5- 1 85 6 9% 79 6 23%
dihydroxycinnamate 10 64 6 14%a 48 6 14%a
100 37 6 27%b 22 6 27%b
Data are mean 6 SD.
a P , 0.05, b P , 0.01
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Hepatocyte growth factor increased the number of tu-
bule structures from 95 6 14 to 212 6 35/1,000 cells (P ,
0.01; Fig. 1C). PTKI reduced the number of tubule struc-
tures to the same extent as the total cell counts, indicating
that PTKI did not specifically inhibit the formation of
tubule structures. In serum-free controls, 115 6 12 mi-
crovilli were counted per 100 mm2 apical cell membrane
area. Incubation with HGF increased this number to 163 6
32/100 mm2 (P , 0.05; Fig. 1D). This effect of HGF was not
inhibited by any PTKI.
Hepatocyte growth factor had multiple effects in PT-1
cells: it bound to a single class of high-affinity binding sites,
enhanced cell proliferation and migration, induced a scat-
tered phenotype, and stimulated tubulogenic cell differen-
tiation. Because the complex actions of HGF on different
target cells might be mediated by different signal cascades
rather than by different receptors [5], we investigated the
effects of different tyrosine-specific protein kinase inhibi-
tors. The common feature of the PTKI used in our study is
inhibition of pp60c-src [9, 10]. As a nonreceptor TK,
pp60c-src is involved in cell growth control via the mitogen-
activated protein kinase signal transduction pathway, re-
sulting in nuclear transcriptional activation [10]. All PTKI
significantly inhibited the effects of HGF on PT-1 cell
proliferation, scattering, and migration, but not cell differ-
entiation. Our data thus indicate that pp60c-src may be
essential in mediating the mitogenic response to HGF in
PT-1 cells, whereas stimulation of tubulogenic cell differ-
entiation may involve a pp60c-src–independent pathway.
Better understanding of the signaling cascades that are
crucial for the different actions of HGF in renal proximal
tubule cells could provide the basis for future therapeutic
use of HGF or substances modulating HGF signal trans-
duction in acute and chronic renal failure.
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Fig. 2. Morphology of PT-1 cells grown for 48 hours in serum-free
medium alone (A, bar 5 10 mm) or in the presence of 1 nM hepatocyte
growth factor (HGF). (B) HGF-induced cell scattering (thin arrows) and
tubulogenesis (thick arrows).
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